Search for: "Actavis Pharma" Results 201 - 220 of 243
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2009, 12:40 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
Actavis Group, Actavis Pharma Manufacturing Pvt Ltd. and Actavis, Inc. [read post]
16 Dec 2009, 3:39 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 Dec 2009, 8:14 pm
Actavis Group et al. 1:09-cv-00940; filed December 8, 2009 in the District Court of Delaware • Plaintiffs: Cephalon Inc.; Cephalon France • Defendants: Actavis Group; Actavis Pharma Manufacturing Pvt Ltd.; Actavis Inc. [read post]
11 Nov 2009, 4:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
11 Nov 2009, 4:02 am
Here is IP Think Tank's weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
11 Nov 2009, 4:02 am
Here is IP Think Tank's weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
14 Oct 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]
7 Oct 2009, 9:59 pm
The agreement ends the litigation over a generic version of Eloxatin ®, a colon cancer drug manufactured and marketed by Sanofi (see "Biotech/Pharma Docket," July 14, 2009). [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
15 Jul 2009, 5:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 May 2009, 10:12 pm
Request for Reglan lawsuit consolidation was opposed by the attorneys for companies involved in the litigation, including Wyeth, who manufactured the brand name Reglan products, and several manufacturers of generic versions, such as Baxter, Pliva, Barr, Duramed, Actavis, Teva and Scwarz Pharma. [read post]
11 May 2009, 5:00 am
.; Schwarz Pharma, Inc.; Actavis, Inc.; and Actavis Elizabeth LLC in Pennsylvania state court for injuries she allegedly suffered from the long-term ingestion of Reglan (or metoclopramide) as prescribed by her physician. [read post]
8 May 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Mar 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 Mar 2009, 2:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
2 Mar 2009, 9:28 pm
In addition to Penwest and Endo agreeing to dismiss their suit with prejudice, Actavis has agreed to dismiss its counterclaims with... [read post]